BeyondSpring Total Assets 2015-2025 | BYSI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

BeyondSpring total assets from 2015 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

BeyondSpring total assets from 2015 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.

Related Stocks
Company Name	Market Cap
AstraZeneca (AZN)	$222.7B
Amgen (AMGN)	$161.5B
Gilead Sciences (GILD)	$142.5B
Vertex Pharmaceuticals (VRTX)	$123.1B
Bristol Myers Squibb (BMY)	$98.7B
GSK (GSK)	$81B
CSL (CSLLY)	$78.2B
Regeneron Pharmaceuticals (REGN)	$60.4B
Alnylam Pharmaceuticals (ALNY)	$42.1B
Argenex SE (ARGX)	$34.4B
BioNTech SE (BNTX)	$27.4B
Royalty Pharma (RPRX)	$20.3B
Biogen (BIIB)	$19.8B
Insmed (INSM)	$18.3B
Illumina (ILMN)	$15.8B
Genmab (GNMSF)	$14B
Genmab (GMAB)	$14B
Incyte (INCY)	$13.6B
Moderna (MRNA)	$13.3B
Exelixis (EXEL)	$12.3B
BioMarin Pharmaceutical (BMRN)	$11.3B
QIAGEN (QGEN)	$10.8B
Ascendis Pharma (ASND)	$10.8B
Swedish Orphan Biovitrum (BIOVF)	$10.4B
Exact Sciences (EXAS)	$10.1B
Verona Pharma American Depositary Share (VRNA)	$8.9B
Bio-Techne Corp (TECH)	$8.5B
Blueprint Medicines (BPMC)	$8.4B
Regencell Bioscience Holdings (RGC)	$8.2B
Roivant Sciences (ROIV)	$7.9B